Axon Enterprise (NASDAQ:AXON) Releases Quarterly Earnings Results, Beats Estimates By $0.20 EPS

Axon Enterprise (NASDAQ:AXON) announced its earnings results on Monday. The biotechnology company reported $1.15 EPS for the quarter, beating the consensus estimate of $0.95 by $0.20, Briefing.com reports. The company had revenue of $460.74 million during the quarter, compared to the consensus estimate of $441.57 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The firm’s revenue for the quarter was up 34.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.51 earnings per share. Axon Enterprise updated its FY 2024 guidance to EPS.

Axon Enterprise Trading Down 0.1 %

AXON stock traded down $0.33 during midday trading on Wednesday, hitting $312.40. 89,969 shares of the company’s stock were exchanged, compared to its average volume of 472,967. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $23.57 billion, a PE ratio of 135.97 and a beta of 0.91. The business has a 50-day simple moving average of $310.77 and a two-hundred day simple moving average of $267.13. Axon Enterprise has a 1-year low of $175.37 and a 1-year high of $329.87.

Analyst Ratings Changes

A number of analysts recently commented on the stock. Morgan Stanley upped their price target on shares of Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, April 26th. Barclays increased their price target on shares of Axon Enterprise from $296.00 to $308.00 and gave the company an “overweight” rating in a research report on Thursday, February 29th. Needham & Company LLC restated a “buy” rating and set a $400.00 price target on shares of Axon Enterprise in a research report on Tuesday. The Goldman Sachs Group increased their price objective on Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a research note on Wednesday, February 28th. Finally, Craig Hallum upped their price objective on shares of Axon Enterprise from $325.00 to $370.00 and gave the company a “buy” rating in a research note on Tuesday. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $327.00.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.